Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8669283 | The Journal of Heart and Lung Transplantation | 2018 | 9 Pages |
Abstract
Pediatric heart transplant survival has improved in the recent era, in concert with increased use of induction therapy. Although induction therapy is associated with decreased rejection, it was not found to directly influence survival on multivariable analysis. Lower risk patients may benefit the most from induction therapy, particularly IL-2RA, which may be correlated with decreased infection and rejection in this cohort.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chesney MD, Elizabeth MSPH, Rebecca MD, Kenneth MD, Erik MD, PhD, Nancy BSN, James K. MD, David PhD, Simon MD,